141 related articles for article (PubMed ID: 7686641)
1. alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.
Van Gool D; De Strooper B; Van Leuven F; Triau E; Dom R
Neurobiol Aging; 1993; 14(3):233-7. PubMed ID: 7686641
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease.
Van Gool D; De Strooper B; Van Leuven F; Dom R
Dementia; 1995; 6(2):63-8. PubMed ID: 7606281
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.
Van Gool D; David G; Lammens M; Baro F; Dom R
Dementia; 1993; 4(6):308-14. PubMed ID: 8136893
[TBL] [Abstract][Full Text] [Related]
4. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease.
Cummings BJ; Su JH; Cotman CW
Exp Neurol; 1993 Dec; 124(2):315-25. PubMed ID: 8287930
[TBL] [Abstract][Full Text] [Related]
5. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
Snow AD; Nochlin D; Sekiguichi R; Carlson SS
Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
[TBL] [Abstract][Full Text] [Related]
6. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
7. Appearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controls.
Van Gool D; Carmeliet G; Triau E; Cassiman JJ; Dom R
Neurosci Lett; 1994 Mar; 170(1):71-3. PubMed ID: 8041517
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.
Bauer J; Strauss S; Schreiter-Gasser U; Ganter U; Schlegel P; Witt I; Yolk B; Berger M
FEBS Lett; 1991 Jul; 285(1):111-4. PubMed ID: 1712317
[TBL] [Abstract][Full Text] [Related]
9. The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid.
Lalowski M; Golabek A; Lemere CA; Selkoe DJ; Wisniewski HM; Beavis RC; Frangione B; Wisniewski T
J Biol Chem; 1996 Dec; 271(52):33623-31. PubMed ID: 8969231
[TBL] [Abstract][Full Text] [Related]
10. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
[TBL] [Abstract][Full Text] [Related]
11. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
[TBL] [Abstract][Full Text] [Related]
12. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions.
de la Monte SM; Wands JR
J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.
Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H
Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360
[TBL] [Abstract][Full Text] [Related]
16. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
17. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
[TBL] [Abstract][Full Text] [Related]
18. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
19. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease.
Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ
FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568
[TBL] [Abstract][Full Text] [Related]
20. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
